Viraj Sanghvi

Cancer biologist and space enthusiast, asst. professor at @columbiacancer @columbia previously @umiamimedicine trained @DrexelUniv @MSKcancercenter.🇮🇳🇺🇸

[Viraj Sanghvi @SanghviLab]

Find me here https://t.co/G2z4TCETVQ

[Marcus Ruscetti Lab @Marcus_Ruscetti]

Do acquired mutations that drive tumorigenesis also contribute to immune evasion that promotes progression and therapy resistance? In a recent study published online @CR_AACR, @katcmurph created new mouse models of prostate cancer to address this question.
https://t.co/fFmoTxACJq

[Viraj Sanghvi @SanghviLab]

Congrats @LoweLabMSKCC on this exciting story

[Lowe Lab @LoweLabMSKCC]

Excited to share our latest work out now in print @Nature! Lead by @almudena_Chaves and @ScottMillman_MD, we uncover how metabolic rewiring via OGDH controls tissue regeneration and stem cell fate in the intestine 🚀🚨 https://t.co/xS1QajleeQ

[Jeff Rathmell @JeffRathmell]

I'm excited to start at @UCCancerCenter as chair of the Ben May Dept for Cancer Research and the @Ludwig_Cancer of UChicago! Things are moving already & we launched a faculty search for tumor microenvironment--take a look & apply!
https://t.co/ZmYK1xkVVl

[Viraj Sanghvi @SanghviLab]

https://t.co/7KvGr6KUMz

[Prof Peter Hotez MD PhD DSc(hon) @PeterHotez]

Many will endure hardships. For me (and committed colleagues), it means the struggle to defend science + counter antiscience forces becomes more complicated/daunting. This time we’ll need better support from the societies, college presidents, elected leaders who care. Tough times

[Ashton Pittman @ashtonpittman]

Just would like to point out that an incredibly "likable" woman ran this time, and it's still really close with that awful, unintelligent monster of a man.

It was never about Hillary's "likability." A lot of people just prefer hateful, ignorant men over smart women.

[Viraj Sanghvi @SanghviLab]

Congratulations @KarunaMDPhD and team - very exciting data in tumor plasticity and metastasis

[Karuna Ganesh @KarunaMDPhD]

Thrilled to share our paper now out @Nature delineating #plasticity during #CRC #metastasis, a fantastic collaboration led by @andrewrmoorman @elliebenitez11, and @f_cambuli from the @KarunaGaneshLab and @dana_per lab! https://t.co/NYQRHfq3gz
https://t.co/Z4GFwqL8G2. A 🧵

[Viraj Sanghvi @SanghviLab]

Congratulations @RRomero_PhD @SawyersLabMSKCC lab and the whole team on this exciting story describing prostate cancer plasticity.

[Rodrigo Romero Rangel @RRomero_PhD]

🚨🚨Now online @NatureCancer, my postdoc work in @SawyersLabMSKCC with @dana_peer 🚨🚨 we establish a powerful organoid transplantation model of prostate cancer neuroendocrine transformation. Open access for all! @HHMINEWS
https://t.co/FJc0WSBvDQ
A 🧵... /1

[Kate Hockemeyer @HockemeyerKate]

Excited to see our story showing that the #stressresponse regulator #HSF1 modulates NK cell anti-tumour immunity out in ⁦@NatureCellBio⁩. Thanks to fantastic work with ⁦@nkourtis⁩ ⁦@iannisaifantis1⁩ and team ⁦@nyulangone⁩ 🧵👇 https://t.co/nb5bGKd7jc

[Leila Akkari @LeilaAkkari1]

Paper 🚨! Ecstatic, proud, grateful …Years of dedication from the whole lab, with the exceptional @djkloosterman and the one of a kind #JohannaErbani at its helm. What a journey all the way to @CellCellPress! How did it start (& end)? A 🧵1/n
https://t.co/d1SPgjFRDr

[Carla Concepcion Crisol @cp_concepcion]

Are you a recent BS graduate with training and experience in bioinformatics and/or computational biology? We are looking for our next lab member joint with @alisontaylorlab @DrEdmondChan labs to study aneuploidy, genetics, and epigenetics in cancer! Join us! 1/2

[Nate Howard @NateHoward2003]

I'm joining the trend! I will donate to VP Kamala Harris' campaign: $0.10 for every like on this tweet, $0.50 for every retweet, and $1.00 for every follow!

(644 followers at the start)

[Iannis Aifantis @iannisaifantis1]

Celebrating our first ever NK/tumor micro environment study that was just accepted for publication. Congrats to the impressive @HockemeyerKate and @nkourtis !! Beautiful art work by @EmmaVIDALL ! Stay tuned for more soon! #NKcells #stress #melanoma #Cancer

[Viraj Sanghvi @SanghviLab]

Very exciting story on new mechanism of drug resistance and need for KRASi-based combination therapies - congratulations to @TuomasTammela and team

[Tuomas Tammela @TuomasTammela]

Paper out!📢 @AnupriyaSingha9 and #HannahStyers from the lab find acute resistance to targeting KRAS in pancreas cancer is surprisingly driven by a classical epithelial state. Co-targeting classical cells and KRAS augments response - clinically important! https://t.co/6U2cDXk9Ah

[Viraj Sanghvi @SanghviLab]

Very exciting and conceptually novel story about polyamines and their role in histone modification and chromatin topology from ⁦@Schvartzman_JM⁩ and team. Congratulations and looking forward to the paper https://t.co/DgHDcyHgLJ

[Viraj Sanghvi @SanghviLab]

Committed mentor and great lab to study cancer Epigenetics.

[Lluis Morey @lluismorey]

We just received a fundable score for our 3rd R01! If you are interested in studying epigenetic mechanisms that contribute to therapy-resistant breast cancer, please DM me!😀🍾

[CU-DLDRC @cudldrc]

Congratulations again to CU-DLDRC Associate Director Timothy Wang, MD and his team for their publication in Cell (June 6, 2024 187(12):3056-3071) @ColumbiaYan

[Viraj Sanghvi @SanghviLab]

@JeffRathmell @LyssiotisLab @JackieEBader @TheMarkFdn @VUMC_VCI @VUMC_Cancer Congratulations @JackieEBader and team - great science!!

[Viraj Sanghvi @SanghviLab]

@Johanna_A_Joyce @elisa_oricchio @EPFL @pezcoller @EACRnews Congratulations 🎈🎉🎊🍾 @elisa_oricchio - that’s amazing and thoroughly deserved recognition. I agree with @Johanna_A_Joyce you’re an inspiration